These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 31505082

  • 1. The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
    Yue L, Wang J, Enomoto H, Fujikoshi S, Alev L, Cheng YY, Skljarevski V.
    Pain Pract; 2020 Feb; 20(2):129-137. PubMed ID: 31505082
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP, Arnold LM, Alaka K, Qiao M, Williams D, Mehta R.
    Pediatr Rheumatol Online J; 2019 May 28; 17(1):27. PubMed ID: 31138224
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study.
    Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, He D, Wang CN, Dueñas H, Skljarevski V, Yue L.
    Osteoarthritis Cartilage; 2017 Jun 28; 25(6):832-838. PubMed ID: 28043937
    [Abstract] [Full Text] [Related]

  • 4. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
    Wang G, Bi L, Li X, Li Z, Zhao D, Chen J, He D, Wang CN, Wu T, Dueñas H, Skljarevski V, Yue L.
    BMC Musculoskelet Disord; 2019 Apr 22; 20(1):174. PubMed ID: 31010413
    [Abstract] [Full Text] [Related]

  • 5. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
    Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A.
    J Pain; 2010 Feb 22; 11(2):109-18. PubMed ID: 19665938
    [Abstract] [Full Text] [Related]

  • 6. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
    Konno S, Oda N, Ochiai T, Alev L.
    Spine (Phila Pa 1976); 2016 Nov 15; 41(22):1709-1717. PubMed ID: 27831985
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
    Murakami M, Osada K, Mizuno H, Ochiai T, Alev L, Nishioka K.
    Arthritis Res Ther; 2015 Aug 22; 17(1):224. PubMed ID: 26296539
    [Abstract] [Full Text] [Related]

  • 8. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
    Konno SI, Alev L, Oda N, Ochiai T, Enomoto H.
    Pain Med; 2019 Aug 01; 20(8):1479-1488. PubMed ID: 30856270
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M.
    Spine (Phila Pa 1976); 2010 Jun 01; 35(13):E578-85. PubMed ID: 20461028
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study.
    Uchio Y, Enomoto H, Ishida M, Tsuji T, Ochiai T, Konno S.
    J Pain Res; 2018 Jun 01; 11():1391-1403. PubMed ID: 30104894
    [Abstract] [Full Text] [Related]

  • 11. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
    Risser RC, Hochberg MC, Gaynor PJ, D'Souza DN, Frakes EP.
    Osteoarthritis Cartilage; 2013 May 01; 21(5):691-4. PubMed ID: 23485934
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM, Zhang S, Pangallo BA.
    Clin J Pain; 2012 May 01; 28(9):775-81. PubMed ID: 22971669
    [Abstract] [Full Text] [Related]

  • 13. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM, Clauw D, Wang F, Ahl J, Gaynor PJ, Wohlreich MM.
    J Rheumatol; 2010 Dec 01; 37(12):2578-86. PubMed ID: 20843911
    [Abstract] [Full Text] [Related]

  • 14. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.
    J Psychiatr Res; 2005 Jan 01; 39(1):43-53. PubMed ID: 15504423
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
    Enomoto H, Fujikoshi S, Tsuji T, Sasaki N, Tokuoka H, Uchio Y.
    J Orthop Sci; 2018 Nov 01; 23(6):1019-1026. PubMed ID: 30126675
    [Abstract] [Full Text] [Related]

  • 16. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
    Williamson OD, Schroer M, Ruff DD, Ahl J, Margherita A, Sagman D, Wohlreich MM.
    Clin Ther; 2014 Apr 01; 36(4):544-51. PubMed ID: 24650448
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
    Itoh N, Uchio Y, Tsuji T, Ishida M, Ochiai T, Konno S.
    J Orthop Sci; 2022 May 01; 27(3):717-724. PubMed ID: 33958268
    [Abstract] [Full Text] [Related]

  • 18. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
    Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, Patrick K.
    J Pain; 2010 Dec 01; 11(12):1282-90. PubMed ID: 20472510
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.
    J Clin Psychiatry; 2007 Nov 01; 68(11):1707-16. PubMed ID: 18052564
    [Abstract] [Full Text] [Related]

  • 20. Estimation of minimum clinically important difference for pain in fibromyalgia.
    Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, Kajdasz DK, Walker DJ, Chappell AS.
    Arthritis Care Res (Hoboken); 2011 Jun 01; 63(6):821-6. PubMed ID: 21312349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.